SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-005009
Filing Date
2017-08-14
Accepted
2017-08-14 09:01:14
Documents
39
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081417.htm 10-Q 183322
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7257
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7332
4 EXHIBIT 32 exh_32.htm EX-32 3778
5 EXHIBIT 10.1 exh_101.htm EX-10.1 123158
6 EXHIBIT 10.2 exh_102.htm EX-10.2 34150
7 EXHIBIT 10.3 exh_103.htm EX-10.3 2464
8 EXHIBIT 10.4 exh_104.htm EX-10.4 27875
9 EXHIBIT 10.5 exh_105.htm EX-10.5 3976
  Complete submission text file 0001171843-17-005009.txt   1817959

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE caps-20170630.xml EX-101.INS 202197
11 XBRL SCHEMA FILE caps-20170630.xsd EX-101.SCH 23970
12 XBRL CALCULATION FILE caps-20170630_cal.xml EX-101.CAL 19089
13 XBRL DEFINITION FILE caps-20170630_def.xml EX-101.DEF 133532
14 XBRL LABEL FILE caps-20170630_lab.xml EX-101.LAB 156435
15 XBRL PRESENTATION FILE caps-20170630_pre.xml EX-101.PRE 150052
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 171027485
SIC: 2834 Pharmaceutical Preparations